Publication on BioC mode of action in Nature Communications
https://rdcu.be/56ts
The article “Structural basis for endotoxin neutralisation and anti-inflammatory activity of thrombin-derived C-terminal peptides” was published on July 17.
https://rdcu.be/56ts
The article “Structural basis for endotoxin neutralisation and anti-inflammatory activity of thrombin-derived C-terminal peptides” was published on July 17.
in2cure AB receives a grant from the Sten K Johnson Foundation in order to develop its preclinical program for improved wound healing.
The BioC concept has been awarded 0.5 million DKK to accelerate the preclinical development and commercialisation of the first product.
in2cure AB has received a grant, together with an industrial partner and the Dermatology and Venereology section of the Department of Clinical Sciences at Lund University, of about SEK 1.4 million from Vinnova’s Medtech4Health strategic innovation program.
Data on the effects of TCP-25 are presented at the European Wound Management Association conference in Bremen 11-13 May 2016
in2cure AB presents at the coming European Tissue Repair Society & the Wound Healing Society (ETRS-WHS 2015) conference in Copenhagen on 21-24 Oct 2015
Since August 2015, in2cure´s office is located at the Lund Life Science Incubator, Medicon Village
We’re happy to announce that in2cure AB has received a 2-year funding from Vinnova (“Vinn-verifiering” program)